Top Markets
Coin of the day
Comera Life Sciences Holdings, Inc. Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

CMRAW
株式のランク #41594
Comera Life Sciences Holdings, Inc. is an early-stage life sciences company... Comera Life Sciences Holdings, Inc. is an early-stage life sciences company dedicated to developing its own innovative therapeutics. These treatments leverage its unique SQore formulation platform, which is engineered to convert biologics typically administered intravenously (IV) into convenient subcutaneous (SQ) versions. The company's pipeline currently features two primary drug candidates: CLS-001, an improved biologic in preclinical development, targets Crohn's and Ulcerative Colitis; and CLS-002, also in preclinical stages, is an enhanced biologic aimed at various oncological indications. Established in 2014, Comera Life Sciences is based in Woburn, Massachusetts.
株価
$0.0008
最終同期: 2024-03-14
時価総額
$15.27K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Comera Life Sciences Holdings, Inc. (CMRAW)

カテゴリー

Comera Life Sciences Holdings, Inc.(CMRAW)のP/S比率
2026 時点のP/S比率 TTM: 0
Comera Life Sciences Holdings, Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Comera Life Sciences Holdings, Inc. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率